15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering AngioDynamics Inc, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $16.00 to $20.00, so the covering firms are broadly aligned. The average target of $18.33 sits 28% above the current $14.33. The rating mix has stayed broadly stable, with Buy-side ratings easing from 4 to 3 over recent months. On the fundamentals, the Street sees revenue growth near 7% this year and 5% next, consensus EPS building from about $-0.08 next quarter toward $-0.04 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to AngioDynamics Inc.
As of Jul, 3 of 3 firms rate ANGO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ANGO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.08
Range $-0.10 – $-0.06 · 3 analysts
Next period, 3 analysts expect AngioDynamics Inc to earn $-0.08 a share (range $-0.10 – $-0.06), versus $0.00 a year earlier. Full-year consensus is $-0.27, growing to $-0.04 the year after.
REVENUE · NEXT QUARTER
$84.1M
Range $82.0M – $85.4M · 3 analysts · +4% YoY
Revenue is expected to reach $84.1M (range $82.0M – $85.4M), +4.0% year-over-year. Full-year consensus is $337.3M, rising to $355.2M next year.
Top analysts covering AngioDynamics Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ANGO.
#1
William Plovanic
Canaccord Genuity · Rank #190
Buy
$18.00+25.6% to target
Overall win rate
36%
+ Follow
#2
Yi Chen
HC Wainwright & Co. · Rank #238
Buy
$19.00+32.6% to target
Overall win rate
34%
+ Follow
#3
Frank Takkinen
Lake Street · Rank #327
Buy
$24.00+67.5% to target
Overall win rate
26%
+ Follow
#4
JY
John Young
Canaccord Genuity
Buy
$20.00+39.6% to target
Coverage
—
+ Follow
#5
IZ
Ilya Zubkov
Freedom Capital Markets
Buy
$16.00+11.7% to target
Coverage
—
+ Follow
ANGO stock forecast FAQ
What is ANGO's average 12-month price target?+
The 3 analysts with a live target average $18.33 for AngioDynamics Inc over the next 12 months, ranging from a $20.00 high to a $16.00 low.
Is ANGO stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ANGO?+
The Street-high target is $20.00 (Canaccord Genuity), and the Street-low is $16.00 (Freedom Broker). The average of all 3 active targets is $18.33.
How many Wall Street analysts cover ANGO?+
3 analysts have an active rating on AngioDynamics Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering ANGO?+
Among analysts who currently cover ANGO, William Plovanic of Canaccord Genuity has the strongest overall Quantellect track record (Rank #190). Their current call is Buy with a $18.00 target.
What is AngioDynamics Inc's projected EPS for next quarter?+
The consensus estimate is $-0.08 per share (range $-0.10 – $-0.06) across 3 analysts. Full-year EPS is projected at $-0.27, rising to $-0.04 the following year.
How much revenue is AngioDynamics Inc expected to report next quarter?+
Consensus revenue is $84.1M (range $82.0M – $85.4M). Full-year revenue is projected at $337.3M, growing to $355.2M next year.
Have analysts been upgrading or downgrading ANGO lately?+
As of Jul, 3 of 3 firms rate ANGO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ANGO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
